Galen Lab Supplies Blog
Non-anticoagulant heparin
Newly introduced. Research grade Non-anticoagulant heparin.
Produced by cleaving heparin primarily at its
antithrombin binding sitesReserves heparin’s anti-viral and anti-inflammatory
activities while greatly reduced its anticoagulant activity Can be used in high dose anti-viral and
anti-inflammatory research without causing bleeding Reports indicate it binds the spike protein of
SARS-CoV-2
13th Oct 2020
Latest cancer publications with siPOOLs- a summary
We're thrilled to see siPOOLs being used increasingly by the research community.Below, we highlight 3 latest publicationsin the field of cancer researchpublished by siPOOL users in Germany, Korea and the USA.Visit our Publication Page for more publications with siPOOLs/raPOOLs.Microprotein CASIMO1 and its role in breast cancerPolycarpou-Schwarz, M., Groß, M., Mestdagh, P., Schott, J., Grund, S. E., Hildenbrand, C., Rom, J., Aulmann, S., Sinn, H.-P., Vandesompele, J., and Diederichs, S.The cancer
…
13th Jun 2018
New SMARTBUFFERS
Smart Solutions for You! • Exactly pre-weighed buffers with pre-set pH • Formulated from analytical grade chemicals • Dissolve-and-go for greater convenience • Guaranteed lot-to-lot reproducibility • Stable at room temperature for 3 years • Ideal for standardizing laboratory work • Save space in stock roomsSmartBuffers - Save Time and Money Biological buffers used daily in research and clinical laboratories are critical for experimental success. However, p
…
3rd Aug 2017
Lonza has acquired HansaBioMed Life Sciences
News ReleaseLonza Invests to Develop Exosomes for Next-Generation Life-Science ApplicationsExosomes technology will leverage Lonza’s portfolio of drug discovery products, as well as its development and manufacturing expertise in mammalian cell cultureLonza, a global leader in the field of biopharmaceutical development and manufacturing, announced today the acquisition of HansaBioMed Life Sciences OÜ (HBM-LS), based in Tallinn, Estonia, a start-up company dedicated to the research and development
…
19th May 2017
New Year New Products
With the new year comes a slew of new products. We have added 4 new Glycosidase Inhibitors to our line up of products. Also in our Glycosaminoglycan Product line we have a new product Chondroitin Sulphate E. These products come with differing degrees of additional 6-O-sulphation to 4-O-sulphated GalNAc residues.In our Exosome product line we have size exclusion columns for exosome isolation. DNA extraction kits are new this year as well as a line of biochemicals spe
…
11th Apr 2017